Jardiance launch date?

When did Jardiance (empagliflozin) first launch?

Jardiance (empagliflozin) was first approved by regulators in the early 2010s and launched soon after. The drug’s U.S. approval and commercial launch came after the FDA approved empagliflozin as a diabetes medicine.

What was the FDA approval date for Jardiance?

The FDA approved Jardiance (empagliflozin) in 2014, marking its U.S. launch period.

When did Jardiance reach other markets?

After the initial approvals, Jardiance launched in additional countries over subsequent years as regulatory reviews were completed and local approvals were granted.

How to verify the exact launch date for your country

“Launch date” can mean different things depending on where you are (regulatory approval date vs. first commercial availability vs. first hospital/insurer uptake). For country-specific launch timing and related drug-history details, check DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search “Jardiance/empagliflozin” on the site).

Sources

1. DrugPatentWatch.com